SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On October 23, 2019, the board of directors (the “Board”) of Cigna Corporation (“Cigna”) appointed Kimberly A. Ross as an independent member of the Board, which appointment is effective June 1, 2020.
Ms. Ross will participate in Cigna’s non-employee director compensation program, amended and restated effective January 1, 2019, as described in Cigna’s proxy statement for the 2019 annual meeting of shareholders, filed with the Securities and Exchange Commission (the “SEC”) on March 15, 2019. A copy of the non-employee director compensation program has been filed as Exhibit 10.18 to Cigna’s Annual Report on Form 10-K for the year ended December 31, 2018.
There is no arrangement or understanding between Ms. Ross and any other person pursuant to which Ms. Ross was selected as a director. Ms. Ross has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended.
The Company will file an amended Form 8-K to disclose Ms. Ross’s committee assignments once determined.
A copy of Cigna's press release announcing the appointment of Ms. Ross is attached to this report as Exhibit 99.1 and incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| Exhibit No. | Description |
| 99.1 | Press release dated October 29, 2019 |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Cigna Corporation | |||
| Date: October 29, 2019 | By: | /s/ Nicole S. Jones | |
| Nicole S. Jones | |||
| Executive Vice President and | |||
| General Counsel | |||
Exhibit 99.1
Kimberly Ross Appointed to Cigna Board of Directors
BLOOMFIELD, Conn. – October 29, 2019 – Cigna Corporation (NYSE:CI) today announced that Kimberly A. Ross has been appointed to Cigna's Board of Directors. Her appointment is effective June 1, 2020.
Ms. Ross served as Senior Vice President and Chief Financial Officer of Baker Hughes (supplier to the oil and gas industry) from September 2014 until July 2017. She is currently a director of Nestlé S.A. and a director and Chair of the Audit Committee of PQ Corporation. Ms. Ross was Executive Vice President and Chief Financial Officer of Avon Products Incorporated (a global consumer products company) from November 2011 until September 2014. Prior to joining Avon, she served as the Executive Vice President and Chief Financial Officer of Royal Ahold N.V. (a food retail company) from 2007 to 2011.
“We are delighted to welcome Kimberly to Cigna’s Board,” said David M. Cordani, Cigna President and Chief Executive Officer. “She brings experience from a variety of different industries — all of which we will be able to draw upon as Cigna works to transform the healthcare experience of consumers and healthcare professionals to one that is more simple, affordable, predictable and personal.”
“Cigna’s Board refreshment process is an important way for the company to continually update the collective skillset of its directors and bring fresh perspectives into the Board room,” said Isaiah Harris, Jr., Cigna Chairman of the Board. “Kimberly’s wealth of finance, international and public company experience — as well as her significant management and leadership skills and perspective — will make her a valuable addition to Cigna’s Board.”
About Cigna
Cigna Corporation is a global health service company dedicated to improving the health, well-being and peace of mind of those we serve. Cigna delivers choice, predictability, affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Cigna Life Insurance Company of New York, Connecticut General Life Insurance Company, Express Scripts companies or their affiliates, and Life Insurance Company of North America. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance. Cigna maintains sales capability in over 30 countries and jurisdictions, and has more than 165 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.
Cover |
Oct. 23, 2019 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Oct. 23, 2019 |
| Entity File Number | 001-38769 |
| Entity Registrant Name | Cigna Corporation |
| Entity Central Index Key | 0001739940 |
| Entity Tax Identification Number | 82-4991898 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 900 Cottage Grove Road |
| Entity Address, City or Town | Bloomfield |
| Entity Address, State or Province | CT |
| Entity Address, Postal Zip Code | 06002 |
| City Area Code | (860) |
| Local Phone Number | 226-6000 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, Par Value $0.01 |
| Trading Symbol | CI |
| Security Exchange Name | NYSE |
| Entity Emerging Growth Company | false |